Boston, MA
Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide.
adicetbio.comThese are collections Adicet Bio is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$98,000,000
Series B
$80,000,000
Post Ipo Equity
$50,000,000
IPO
Unknown
Series A
$40,000,000
Series A
$25,000,000
Series A
$51,000,000
Series Unknown
$14,625,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Adicet Bio.